#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cutaneous T-cell lymphoma B-cell small lymphocytic lymphoma recurrent B-cell lymphoma Alport's syndrome Chondrodystrophy Congenital ectodermal dysplasia Heart disease congenital Haemophilia Ectonucleotide pyrophosphatase/phosphodiesterase 1 deficiency Arrhythmia Retinoblastoma Vascular calcification Phenylketonuria Antisynthetase syndrome Biotinidase deficiency More trials…

    Learn about Rare Diseases

    Gaucher’s disease type III Methylmalonic acidaemia – Trials in Disease Mantle cell lymphoma stage IV – Diagnostics Piriformis syndrome – Trials in Disease Glycogen storage disease type I – Trials in Disease Antithrombin III deficiency – Trials in Disease Small intestine leiomyosarcoma Ocular melanoma – Treatment Primary biliary cholangitis – Life with Disease Systemic mastocytosis – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Infliximab ANUMIGILIMAB AB521 Mometasone Furoate Cefepime Hydrochloride Garetosmab Etelcalcetide Doxecitine Zanubrutinib IMMUNOSTEM Iodixanol Losartan Potassium Morphine Sulfate METHYLPHENIDATE Vepdegestrant Teclistamab [89ZR]ZR-DFO-CIT-013 Somatropin TUB-030 177Lu-Dpi-4452 More therapies…

    Learn about Your Condition

    Colorectal cancer Seizure Pneumothorax Erectile dysfunction Adenocarcinoma Heart transplant Relapsing multiple sclerosis Ependymoma malignant Alopecia areata Intracranial aneurysm Paraganglion neoplasm Transplantation complication Cervix carcinoma stage II Henoch-Schonlein purpura H1N1 influenza More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Neuropsychiatrie s.r.o.

Neuropsychiatrie s.r.o.

Terronska 580/19, Bubenec, Prague, 160 00, Czechia

Want to learn more about this study or check if you can participate? Contact us.

  • Oral Semaglutide in People With Mild Cognitive Impairment or Mild Dementia of the Alzheimer’s Type

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Semaglutide
    Austria Belgium Bulgaria Czechia Denmark Finland +15

  • Study on the Effects of Semaglutide in Patients with Early Alzheimer’s Disease

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Semaglutide
    Austria Belgium Bulgaria Croatia Czechia Denmark +15

  • Study on the Effects of AR1001 (Mirodenafil Dihydrochloride) for Patients with Early Alzheimer’s Disease

    Not recruiting

    3 1
    Investigated Drugs:
    • Mirodenafil Dihydrochloride
    Czechia Denmark France Germany Italy The Netherlands +2

  • Study of XPro1595 for Patients with Early Alzheimer’s Disease and Inflammation Markers

    Not recruiting

    2 1
    Investigated Diseases:
    • Dementia of the Alzheimer’s type uncomplicated
    Investigated Drugs:
    • Pegipanermin
    Czechia France Germany Poland Slovakia Spain

  • Study on Valbenazine for Patients with Schizophrenia Not Responding Well to Antipsychotic Treatment

    Not recruiting

    3 1
    Investigated Diseases:
    • Schizophrenia
    Investigated Drugs:
    • Valbenazine Ditosylate
    Czechia Germany Italy Romania Slovakia Spain
Previous Page
1 2

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!